Podcast: How Alcidion is raising the bar in patient healthcare

WRITTEN BY: Meagan Evans

PUBLISHED: 09-05-2019

Alcidion Group Limited (ASX:ALC) ­­is leading the way in healthcare informatics — a particularly lucrative area of healthcare that’s undergoing a rapid shift to digital patient data, driven by the need for real-time healthcare analytics.

Having experienced an impressive share price run, gaining more than 150% since early March, the company’s potential in this space is starting to gain recognition.

In this Next Tech Stock podcast Alcidion Group (ASX:ALC) Managing Director Kate Quirke speaks with Meagan Evans discussing recent developments, the quarterly report, and what’s ahead for the group into FY20.


Just as a reminder, here's why we like Alcidion as an investment.

7 reasons to consider for an investment in Alcidion

Alcidion’s health informatics technology products — Patientrack, Miya and Smartpage — and specialist IT services are being adopted by major hospital groups worldwide. The company’s revenues are on the rise and it is cash flow positive.

It seems that ALC really is ‘Changing the Game in Real-Time Healthcare Analytics’ and we expect plenty more to come.

Have you heard about Raisebook?

Joining Raisebook will give you free access to opportunities not normally available to general retail investors – however you must qualify as a sophisticated investor under Section 708 of the Corporations Act.

These opportunities are as diverse as stock placements, seed capital raisings, IPOs, options underwritings. Plus a whole host of other high risk, high reward investment opportunities not available to the general public (careful – this stuff is high risk!).

Are you a sophisticated investor?
Find out more
Please note: Raisebook is a related entity of S3 Consortium Pty Ltd as defined in Section 9 of the Corporations Act 2001.


Thanks for subscribing!